INNOVATE Corp. (VATE)
NYSE: VATE · Real-Time Price · USD
4.520
-0.160 (-3.42%)
Dec 31, 2025, 4:00 PM EST - Market closed
INNOVATE Revenue
INNOVATE had revenue of $347.10M in the quarter ending September 30, 2025, with 43.31% growth. This brings the company's revenue in the last twelve months to $1.10B, down -10.69% year-over-year. In the year 2024, INNOVATE had annual revenue of $1.11B, down -22.20%.
Revenue (ttm)
$1.10B
Revenue Growth
-10.69%
P/S Ratio
0.05
Revenue / Employee
$347,960
Employees
3,161
Market Cap
61.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.11B | -315.90M | -22.20% |
| Dec 31, 2023 | 1.42B | -214.30M | -13.09% |
| Dec 31, 2022 | 1.64B | 432.10M | 35.85% |
| Dec 31, 2021 | 1.21B | 488.30M | 68.11% |
| Dec 31, 2020 | 716.90M | -1.44B | -66.71% |
| Dec 31, 2019 | 2.15B | -26.00M | -1.19% |
| Dec 31, 2018 | 2.18B | -937.30M | -30.07% |
| Dec 31, 2017 | 3.12B | 142.80M | 4.80% |
| Dec 31, 2016 | 2.97B | 2.77B | 1,365.79% |
| Dec 31, 2015 | 202.88M | 115.32M | 131.71% |
| Dec 31, 2014 | 87.56M | -143.13M | -62.04% |
| Dec 31, 2013 | 230.69M | -72.27M | -23.86% |
| Dec 31, 2012 | 302.96M | -109.02M | -26.46% |
| Dec 31, 2011 | 411.98M | 129.97M | 46.08% |
| Dec 31, 2010 | 282.02M | -550.82M | -66.14% |
| Dec 31, 2008 | 832.84M | -63.19M | -7.05% |
| Dec 31, 2007 | 896.03M | -97.01M | -9.77% |
| Dec 31, 2006 | 993.03M | -174.98M | -14.98% |
| Dec 31, 2005 | 1.17B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| RTX Corporation | 85.99B |
| The Boeing Company | 80.76B |
| Lockheed Martin | 73.35B |
| Caterpillar | 64.67B |
| Deere & Company | 45.63B |
| GE Aerospace | 43.95B |
| Honeywell International | 40.67B |
| GE Vernova | 37.67B |
VATE News
- 15 days ago - MediBeacon® Next Generation TGFR™ System Receives FDA Approval - GlobeNewsWire
- 7 weeks ago - INNOVATE Corp. (VATE) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - INNOVATE Corp. Announces Third Quarter 2025 Results - GlobeNewsWire
- 2 months ago - INNOVATE Corp. to Report Third Quarter 2025 Results on November 12th - GlobeNewsWire
- 2 months ago - MediBeacon receives regulatory approval to sell the Transdermal GFR System in China - GlobeNewsWire
- 2 months ago - INNOVATE's Portfolio Company DBM Global to Pay Cash Dividend - GlobeNewsWire
- 4 months ago - INNOVATE's Portfolio Company, R2, has Explosive Growth and Global Reach with Glacial® Skin Continuing to Redefine Aesthetic Innovation - GlobeNewsWire
- 5 months ago - INNOVATE Corp. (VATE) Q2 2025 Earnings Call Transcript - Seeking Alpha